NIH Reports Positive Results from Experimental Ebola Vaccine
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers at the National Institutes of Health (NIH).
According to NIH, the candidate vaccine, which was co-developed by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and GlaxoSmithKline (GSK), was tested at the NIH Clinical Center in Bethesda.
“The unprecedented scale of the current Ebola outbreak in West Africa has intensified efforts to develop safe and effective vaccines, which may play a role in bringing this epidemic to an end and undoubtedly will be critically important in preventing future large outbreaks,” said NIAID Director Anthony S. Fauci, M.D. “Based on these positive results from the first human trial of this candidate vaccine, we are continuing our accelerated plan for larger trials to determine if the vaccine is efficacious in preventing Ebola infection.”
You can read more about this study online here.
Related:
UPDATED: Remembering Dr. Ulder Tillman (VIDEO)
UPDATED 1.10.17 Funeral services have been announced for Dr. Ulder Tillman. A viewing will be held at 10 a.m. on Friday at The Church of Jesus Christ of Latter-Day Saints in Kensington. The service will follow at 11 a.m. on Jan. 13. For more information, visit the county’s website, here. ORIGINAL POST Montgomery County is […]
County Health Officer Gives Update on Ebola, TB and School Vaccination Requirements
The county’s health officer updated the Montgomery County Council Tuesday on the topics of Ebola, tuberculosis and school vaccinations. Dr. Ulder Tillman gives a public health briefing to the county council about twice a year. Of the 11,001 Montgomery County Public Schools’ sixth graders entering seventh grade in August, 7,098 still do not have the required Tdap (tetanus-diphtheria-acellular […]
Patient Admitted with Ebola Virus Discharged from NIH Clinical Center
UPDATED April 9, 5:44 p.m. The American healthcare worker admitted to the NIH Clinical Center on March 13 with the Ebola virus was discharged today in good condition after having been successfully treated at the NIH Clinical Center Special Clinical Studies Unit. According to NIH officials, the individual is no longer contagious to the community. No […]
Five Things to Know Today, April 8, in Montgomery County
Here are your five things to know today, April 8, in Montgomery County: 1. A Hate Crime: Gaithersburg police are looking for the vandal(s) who defaced a synagogue in the Lakelands community and city leaders are speaking out about the incident. 2. Getting Better: NIH officials have upgraded the condition of a patient with the Ebola […]
Five Things to Know Today, March 13, in Montgomery County
Here are your five things to know today, March 13, in Montgomery County. 1. The 41st annual Public Safety Awards ceremony takes place today at the Bethesda North Marriott. 2. A healthcare worker diagnosed with the Ebola virus is scheduled to be admitted to NIH today. 3. Meet the two MCPS students who are campaigning […]
Zalgen Labs Plans to Ramp Up Production for Ebola Test (VIDEO)
In this MyMCMedia Extra video, Zalgen Labs’ co-founder Dr. Luis Branco said as the newly approved rapid diagnostic test for Ebola hits the market he will need to ramp up production at his startup company. Related:
"This is A Game Changer For Ebola" (VIDEO)
In this MyMCMedia Extra video, Zalgen Labs’ co-founder Dr. Luis Branco said the approval of a rapid diagnostic test for Ebola is a gamechanger. Related:
Zalgen Labs Co-Founder Plans Return Work Trip to Africa (VIDEO)
In this MyMCMedia Extra video, Dr. Luis Branco said he plans to return to Eastern Sierra Leone sometime this year to continue work on the recently approved rapid diagnostic test for the Ebola virus. Despite progress, he said there are always more questions to answer. Related:
Dr. Luis Branco: "I Was Exposed to a Lot of Ebola in the Lab" (VIDEO)
In this MyMCMedia Extra video, Zalgen Labs’ co-founder Dr. Luis Branco talks about his work on the rapid diagnostic test for Ebola late last year in Africa and what happened when he returned to the United States. The World Health Organization approved a rapid diagnostic test for Ebola last week. Related:
Zalgen Labs Expects to Expand Following Rapid Ebola Test Approval (VIDEO)
It’s called a gamechanger: a rapid diagnostic test for Ebola has recently been approved and a startup Germantown company, Zalgen Labs, played a part in the development of that test. MyMCMedia’s Sonya Burke reports. You can find more information about this development and the Viral Hemorrhagic Fever Consortium that made it happen on its website. […]
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia